We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.21%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$822M
AUM Growth
-$41.1M
(-4.8%)
Cap. Flow
-$36.7M
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
55.16%
Holding
88
New
20
Increased
19
Reduced
10
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour
UAA
|
+$22.1M |
| 2 |
Avery Dennison
AVY
|
+$17.1M |
| 3 |
Humana
HUM
|
+$14.3M |
| 4 |
Generac Holdings
GNRC
|
+$12.9M |
| 5 |
RAPT
RAPT Therapeutics
RAPT
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$25.9M |
| 2 |
Advanced Micro Devices
AMD
|
+$23.5M |
| 3 |
Crown Holdings
CCK
|
+$22.2M |
| 4 |
Aurinia Pharmaceuticals
AUPH
|
+$20.5M |
| 5 |
Vertiv
VRT
|
+$18.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.26% |
| 2 | Consumer Discretionary | 10.5% |
| 3 | Technology | 9.81% |
| 4 | Communication Services | 7.28% |
| 5 | Industrials | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
ON Semiconductor
ON
$31.6B
| – | – |
-318,200
| Closed | -$12.2M |
|
77
PUT
Invesco QQQ Trust
QQQ
$484B
| – | – |
-178,500
| Closed | -$63.3M |
|
78
CALL
uniQure
QURE
$3.22B
| – | – |
-200,000
| Closed | -$6.16M |
|
|
RAPT
79
CALL
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-25,000
| Closed | -$6.36M |
|
80
PUT
Sea Limited
SE
$69.5B
| – | – |
-11,500
| Closed | -$3.16M |
|
81
TransDigm Group
TDG
$67.7B
| – | – |
-12,850
| Closed | -$8.32M |
|
|
82
Vertiv
VRT
$105B
| – | – |
-669,222
| Closed | -$18.3M |
|
83
Workday
WDAY
$44.4B
| – | – |
-21,000
| Closed | -$5.01M |
|
84
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.51B
| – | – |
-159,700
| Closed | -$15.4M |
|
|
RXDX
85
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – |
-8,317
| Closed | -$204K |
|
|
XLRN
86
DELISTED
Acceleron Pharma
XLRN
| – | – |
-65,000
| Closed | -$8.16M |
|
|
FLXN
87
DELISTED
Flexion Therapeutics, Inc.
FLXN
| – | – |
-893,580
| Closed | -$7.35M |
|
|
SRNG
88
DELISTED
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
| – | – |
-403,900
| Closed | -$4.02M |
|
Similar funds
GC
ICP
SAA
GIG
SI
PAMI
BDP
PTC
Kingdon Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Kingdon Capital Management held 88 positions worth $822M, down 4.8% from $863M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Kingdon Capital Management withdrew a net $36.7M in Q3 2021, closing 26 positions and reducing 10 holdings. Its most notable exit was Advanced Micro Devices, an estimated $23.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Kingdon Capital Management opened a new position in Under Armour worth $20.2M.
- Kingdon Capital Management's largest Q3 2021 buy was Under Armour: 1,000,000 shares worth $20.2M.
- Kingdon Capital Management added most to RAPT Therapeutics in Q3 2021, an estimated $12.5M increase.
- Kingdon Capital Management's biggest Q3 2021 reduction was Amazon, cutting an estimated $25.9M.
- Kingdon Capital Management fully exited Advanced Micro Devices in Q3 2021, selling an estimated $23.5M.
- Kingdon Capital Management's ten largest holdings make up 55% of its $822M portfolio in Q3 2021.
- Kingdon Capital Management opened 20 new positions and closed 26 in Q3 2021.
- Kingdon Capital Management's portfolio value fell 4.8% quarter-over-quarter to $822M.
Based on Kingdon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.